
AbbVie sue NHS over hepatitis C drug procurement
pharmafile | November 8, 2018 | News story | Business Services | AbbVie, NHS, britain, court, hep C, hepatitis, ruling
American pharma firm AbbVie are suing Britain’s NHS after claiming that the health service’s procurement of hepatitis C drugs breached procurement rules.
AbbVie have claimed that the NHS failed in its duty to treat all bidders fairly after it launched the single largest procurement of medicines ever conducted by the NHS in spring of this year.
The procurement which was launched as part of an effort to lower the price of drugs for hepatitis C, saw NHS England offer three year contracts with the option of extension for an additional two years.
However NHS England has said that the Illinois-based firm’s allegation was “embarrassing for lack of particulars”.
Significantly the court action is set to delay the implementation of the programme. Furthermore, the case has so far been heard in private. However confidentiality restrictions were lifted by Mr Justice Fraser in autumn of this year.
Louis Goss
Related Content

PlaqueTec coronary disease trial reaches 100 patients across eight NHS centres
PlaqueTec’s BIOPATTERN clinical trial has recruited its 100th patient and expanded to eight NHS specialist …

“That gap between innovation and delivery was what stood out to me most”
Pharmafile chats with Camunda’s Natosha McNeal about the vital role of delivery, onboarding AI and …

Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study
People in their forties account for almost three-quarters of those who do not attend NHS …





